Connect with UsInvestorsCareersMediaScienceContact Us
HomeNewsBank Of China Group Insurance and Pfizer Hong Kong Announce Partnership to Increase Health LiteracyBank Of China Group Insurance and Pfizer Hong Kong Announce Partnership to Increase Health Literacy

HONG KONG, 2 SEPTEMBER 2022 — Bank of China Group Insurance and Pfizer Hong Kong today signed a memorandum of understanding (MOU) to increase health literacy among the Hong Kong population. The agreement builds on the expertise from both organizations, and also seeks to enable the improvement of overall population health while building a healthy Hong Kong together.

For two years, both parties will focus on the mutual co-operation of conducting medical knowledge exchange, disease awareness education, digital disease awareness content exchange, and other agreed partnership initiatives with the aim to enhance the development of a robust and digital healthcare ecosystem with relevant stakeholders in Hong Kong.

“At Pfizer, we believe it is very important for the Hong Kong population to take a proactive approach to managing their health. Good health literacy empowers effective communication with healthcare providers, making informed and shared decisions about health and treatments. Prevention is the best cure. Health is wealth and we hope to make a difference to the community we live in. Therefore, we are excited to partner with Bank of China Group Insurance who share our values and focus”, said Mr. Krishnamoorthy Sundaresan, General Manager of Pfizer Hong Kong.
 
Mr. Gong Jianzhong, Chairman of Bank of China Group Insurance said, “As a market-leading general insurance company, BOC Group Insurance focuses on evolving our role from simply payer of medical fee to convener of healthcare initiatives. To accomplish it, we keep on enriching our services, from the provision of insurance products to the construction of a comprehensive healthcare ecosystem. Shared the common vision and mission, Pfizer and BOC Group Insurance are both committed to make our community a better place to live. By forging a partnership between pharmaceutical company and medical insurer, Pfizer and BOC Group Insurance will complement each other by leveraging their expertise and strengths. The collaboration will thrive with the synergy created from our partnership.”.
“作為具有市場領導地位的一般保險公司,中銀集團保險集中精力由單一的財務承擔者向召集人轉變,從提供簡單的健康保險產品向綜合性的健康管理服務升級。輝瑞香港和中銀集團保險肩負相同使命,即致力於讓市民生活更美好。分別作為醫療產品的提供者和醫療保障的財務承擔者的獨特優勢,令我們合作的深化必將實現優勢互補、強強聯合。.”  
 

Moving forward, the two companies through joint efforts together, will focus on a patient-centric approach towards increasing health literacy so as to address the needs of the Hong Kong population in a way that is most relevant to them.
 
“We aim to bring together the expertise and resources from each company so as to create results that matter, thus enabling this collaboration to proactively improve the quality of life of the Hong Kong population and eventually help to build a healthier Hong Kong,” added Mr. Sundaresan.
 
“This collaboration represents our joint effort to innovate the service model of medical insurance and to build up a vibrant healthcare ecosystem. We are confident that our works will be beneficial to the steady progress of healthcare services and help bring a better and healthier living to Hong Kong people.”, added Mr. Gong.
此次合作是創新健康險服務模式和打造健康生態的有益探索和嶄新實踐,必將共同促進香港健康服務的穩步發展,為香港市民帶來更健康、美好的生活。”

About Bank of China Group Insurance
BOC Group Insurance, a wholly owned subsidiary of Bank of China Limited, was established in Hong Kong on 23 July, 1992. We hold the operation licenses for all 17 types of general insurance authorized by the Insurance Authority of Hong Kong, with a full range of insurance products, including health insurance. Relying on the vast network of BOC Group, intensively complementary banking-insurance cooperation and strong professional expertises, we have steadily expanded our business into a company owning 4 branches, 1 subsidiary and 3 affiliates. Our premium income ranks among the top insurance companies in Hong Kong general insurance market for years and we have been rated ‘A-’ with a rating outlook of “stable” by professional rating companies for consecutive years since 2007.

About Pfizer: Breakthroughs That Change Patients’ Lives
At Pfizer, we apply science and our global resources to bring therapies to people that extend and significantly improve their lives. We strive to set the standard for quality, safety and value in the discovery, development and manufacture of health care products, including innovative medicines and vaccines. Every day, Pfizer colleagues work across developed and emerging markets to advance wellness, prevention, treatments and cures that challenge the most feared diseases of our time. Consistent with our responsibility as one of the world's premier innovative biopharmaceutical companies, we collaborate with health care providers, governments and local communities to support and expand access to reliable, affordable health care around the world. For more than 170 years, we have worked to make a difference for all who rely on us.

Careers News Useful LinksHealthcare ProfessionalUseful LinksPrivacy PolicyTerms of UseConnect with Us Privacy statement Terms of Use Distributors Grant Seekers Media Copyright © 2022 pfizer inc. The product information provided in this site is intended only for health professionals who reside in hong kong, and the products discussed herein may have different product labeling in different countries/regions. Pfizer corporation hong kong limited is a pharmaceutical company committed to helping people improve their health by discovering and developing medicines.